Verano Holdings (VRNO) Interest Expenses (2021 - 2026)

Verano Holdings' (VRNO) quarterly Interest Expenses came in at $149.9 million in Q1 2026, up 126.18% year-on-year from $66.3 million in Q1 2025, and up 559.3% on a QoQ basis from -$32.6 million in Q4 2025.

Verano Holdings (VRNO) Interest Expenses (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Interest Expenses data on file, last reported at $149.9 million in Q1 2026.

  • On a quarterly basis, Interest Expenses rose 126.18% year-over-year to $149.9 million in Q1 2026; TTM through Mar 2026 was $149.9 million, a 126.18% increase from a year earlier, with the FY2025 full-year figure at $289.7 million, up 451.18% from the prior year.
  • Interest Expenses for Q1 2026 stood at $149.9 million, up from -$32.6 million in the prior quarter.
  • Over the last five years, Interest Expenses for VRNO reached as high as $160.4 million in Q2 2025 and fell as low as -$32.6 million in Q4 2025.
  • Historically, Interest Expenses has averaged $66.7 million across 5 years, with a median of $90.3 million in 2024.
  • Across the five-year window, Interest Expenses soared 806.81% in 2023 and slumped 356.37% in 2025, its largest moves.
  • Year by year, Interest Expenses stood at $16.3 million in 2022, then decreased by 10.03% to $14.7 million in 2023, then declined by 13.47% to $12.7 million in 2024, then slumped by 356.37% to -$32.6 million in 2025, then soared by 559.3% to $149.9 million in 2026.
  • Per Business Quant data, the three most recent Interest Expenses figures were $149.9 million in Q1 2026, -$32.6 million in Q4 2025, and $66.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 944.51 Mn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 1.77 Bn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 1.21 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 590.20 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 57.00 Mn
10 Verano Holdings 1.99 Bn 1.92 Bn 98.98 Mn 149.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 149.86 Mn
Mar 31, 2026 149.86 Mn
Dec 31, 2025 -32.63 Mn
Dec 31, 2025 -32.63 Mn
Sep 30, 2025 66.26 Mn
Sep 30, 2025 66.26 Mn
Jun 30, 2025 160.44 Mn
Jun 30, 2025 160.44 Mn
Mar 31, 2025 66.26 Mn
Mar 31, 2025 66.26 Mn
Dec 31, 2024 12.73 Mn
Dec 31, 2024 12.73 Mn
Sep 30, 2024 92.34 Mn
Sep 30, 2024 92.34 Mn
Jun 30, 2024 90.34 Mn
Jun 30, 2024 90.34 Mn
Mar 31, 2024 90.34 Mn
Mar 31, 2024 90.34 Mn
Dec 31, 2023 14.71 Mn
Dec 31, 2023 14.71 Mn